CLPT
Price
$13.11
Change
+$0.41 (+3.23%)
Updated
Mar 12, 01:44 PM (EDT)
Capitalization
183.44M
62 days until earnings call
LAB
Price
$1.16
Change
+$0.02 (+1.75%)
Updated
Mar 12, 03:54 PM (EDT)
Capitalization
1.04B
56 days until earnings call
Ad is loading...

CLPT vs LAB

Header iconCLPT vs LAB Comparison
Open Charts CLPT vs LABBanner chart's image
ClearPoint Neuro
Price$13.11
Change+$0.41 (+3.23%)
Volume$2.1K
Capitalization183.44M
Standard BioTools
Price$1.16
Change+$0.02 (+1.75%)
Volume$500
Capitalization1.04B
CLPT vs LAB Comparison Chart
Loading...
CLPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLPT vs. LAB commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLPT is a Hold and LAB is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (CLPT: $12.72 vs. LAB: $1.14)
Brand notoriety: CLPT and LAB are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CLPT: 111% vs. LAB: 67%
Market capitalization -- CLPT: $183.44M vs. LAB: $1.04B
CLPT [@Medical Specialties] is valued at $183.44M. LAB’s [@Medical Specialties] market capitalization is $1.04B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLPT’s FA Score shows that 0 FA rating(s) are green whileLAB’s FA Score has 1 green FA rating(s).

  • CLPT’s FA Score: 0 green, 5 red.
  • LAB’s FA Score: 1 green, 4 red.
According to our system of comparison, LAB is a better buy in the long-term than CLPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLPT’s TA Score shows that 4 TA indicator(s) are bullish while LAB’s TA Score has 5 bullish TA indicator(s).

  • CLPT’s TA Score: 4 bullish, 6 bearish.
  • LAB’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, LAB is a better buy in the short-term than CLPT.

Price Growth

CLPT (@Medical Specialties) experienced а -5.15% price change this week, while LAB (@Medical Specialties) price change was +7.55% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.90%. For the same industry, the average monthly price growth was -8.26%, and the average quarterly price growth was -3.51%.

Reported Earning Dates

CLPT is expected to report earnings on May 13, 2025.

LAB is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Medical Specialties (-2.90% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LAB($1.04B) has a higher market cap than CLPT($183M). CLPT YTD gains are higher at: -17.295 vs. LAB (-34.857). CLPT has higher annual earnings (EBITDA): -20.99M vs. LAB (-54.46M). LAB has more cash in the bank: 115M vs. CLPT (23.1M). CLPT has less debt than LAB: CLPT (13.9M) vs LAB (98.2M). LAB has higher revenues than CLPT: LAB (106M) vs CLPT (24M).
CLPTLABCLPT / LAB
Capitalization183M1.04B18%
EBITDA-20.99M-54.46M39%
Gain YTD-17.295-34.85750%
P/E RatioN/AN/A-
Revenue24M106M23%
Total Cash23.1M115M20%
Total Debt13.9M98.2M14%
FUNDAMENTALS RATINGS
CLPT vs LAB: Fundamental Ratings
CLPT
LAB
OUTLOOK RATING
1..100
594
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
29
Undervalued
PROFIT vs RISK RATING
1..100
70100
SMR RATING
1..100
9596
PRICE GROWTH RATING
1..100
6193
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LAB's Valuation (29) in the Medical Specialties industry is in the same range as CLPT (53) in the null industry. This means that LAB’s stock grew similarly to CLPT’s over the last 12 months.

CLPT's Profit vs Risk Rating (70) in the null industry is in the same range as LAB (100) in the Medical Specialties industry. This means that CLPT’s stock grew similarly to LAB’s over the last 12 months.

CLPT's SMR Rating (95) in the null industry is in the same range as LAB (96) in the Medical Specialties industry. This means that CLPT’s stock grew similarly to LAB’s over the last 12 months.

CLPT's Price Growth Rating (61) in the null industry is in the same range as LAB (93) in the Medical Specialties industry. This means that CLPT’s stock grew similarly to LAB’s over the last 12 months.

CLPT's P/E Growth Rating (100) in the null industry is in the same range as LAB (100) in the Medical Specialties industry. This means that CLPT’s stock grew similarly to LAB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLPTLAB
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 15 days ago
82%
Bullish Trend 8 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 14 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
CLPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NUIAX29.38N/A
N/A
Nuveen International Dividend Growth A
RGGCX22.55N/A
N/A
Victory RS Global C
GMVCX14.40N/A
N/A
Goldman Sachs Small/Mid Cap Value C
FGIWX11.56N/A
N/A
Nuveen Global Infrastructure R6
HQIIX20.36N/A
N/A
Hartford Equity Income I

CLPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLPT has been loosely correlated with ICUI. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CLPT jumps, then ICUI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLPT
1D Price
Change %
CLPT100%
+4.09%
ICUI - CLPT
48%
Loosely correlated
+6.87%
ALGN - CLPT
37%
Loosely correlated
+1.07%
LAB - CLPT
35%
Loosely correlated
+5.56%
TNDM - CLPT
35%
Loosely correlated
-1.49%
ILMN - CLPT
34%
Loosely correlated
-1.69%
More